Vitesco Technologies Group AG
OTC:VTSCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vitesco Technologies Group AG
OTC:VTSCF
|
DE |
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
Cooper-Standard Holdings Inc
NYSE:CPS
|
US |
|
National Australia Bank Ltd
ASX:NAB
|
AU |
|
V
|
Very Good Food Company Inc
XTSX:VERY
|
CA |
|
Coca-Cola Co
NYSE:KO
|
US |
|
X
|
Xero Ltd
F:0XE
|
NZ |
|
Wilmar International Ltd
SGX:F34
|
SG |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
Amplitude Inc
NASDAQ:AMPL
|
US |
|
C
|
China Literature Ltd
OTC:CHLLF
|
CN |
|
American Airlines Group Inc
NASDAQ:AAL
|
US |
|
Procter & Gamble Co
NYSE:PG
|
US |
|
D
|
Dr Reddy's Laboratories Ltd
F:RDDA
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VTSCF's stock price target?
Not Available
VTSCF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Vitesco Technologies Group AG?
Projected CAGR
1%
Over the last 4 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Vitesco Technologies Group AG?
Projected CAGR
26%
The compound annual growth rate for Operating Income over the next 3 years is 26%.